A Study of SCTB35 in Patients with Systemic Lupus Erythematosus

Phase 1/2 Recruiting 168 enrolled Sinocelltech Ltd.

NaSingle-groupOpen-labelTreatment

Summary

This study is a multicenter Phase Ib/II clinical trial aimed at evaluating the safety, tolerability and efficacy of SCTB35 in patients with systemic lupus erythematosus (SLE).

Timeline

Start: 2025-02
Primary completion: 2027-05
Completion: 2028-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	SCTB35	Unknown	—	Subcutaneous

A Study of SCTB35 in Patients with Systemic Lupus Erythematosus

Summary

Timeline

Drugs

Indications